\n\n\n \n \n\n \n \n \n \n\n\n \n\n \n\n Nov 17, 2009 8:30 AM EST \n\n \n AVANIR Pharmaceuticals Invites Investors to Fourth Quarter and Fiscal Year End Conference Call - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 13, 2009 6:49 AM EST \n\n \n RothmanResearch.com Completes Analysis on KSU, PCLN, NUVA, PWAV, AVNR and WCRX - Marketwire\n \n \n | \n\n \n\n \n\n \n\n Nov 11, 2009 8:30 AM EST \n\n \n AVANIR to Present at the Lazard Healthcare Conference - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 10, 2009 8:30 AM EST \n\n \n Avanir Pharmaceuticals Announces Zenvia Safety and Efficacy Data from Star Trial Open Label Extension - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 04, 2009 5:34 AM EST \n\n \n AnalystChoice.com Gives Technical review on ARTG, BEAV, NUVA, ACAS, CEDC and AVNR - Marketwire\n \n \n | \n\n \n\n \n\n \n\n Nov 03, 2009 6:51 AM EST \n\n \n Trading Outlook for Avanir Pharmaceuticals Inc. Issued by InvestorSoup.com - GlobeNewswire\n \n \n | \n\n \n\n \n\n \n\n Oct 26, 2009 7:10 AM EDT \n\n \n WallStSense.com Offers Detailed Analysis on DWA, SVNT, ATVI, SSRI, CIEN and AVNR - Marketwire\n \n \n | \n\n \n\n \n | \n
\n\n
\n\n");